I R Welshman

835 citations
21 papers · 663 indexed · h-index 12
Topics
Diabetes Treatment and Management (5 papers)Drug Transport and Resistance Mechanisms (3 papers)Lipid metabolism and biosynthesis (3 papers)
Partner nations
United States

In The Last Decade

I R Welshman

21 papers receiving 637 citations

Peers

I R Welshman
Comparison fields: 5 of 88
  • Infectious Diseases 332
  • Pharmacology 293
  • Clinical Biochemistry 146
  • Molecular Biology 97
  • Epidemiology 79
Replace Nancy K. Hopkins with:
Nancy K. Hopkins United States
Steven C. Boike United States
M J Hauer United States
Dennis J. Stalker United States
Yingmei Liu China
Donald S. North United States
R.P. Stryd United States
Edward J. Mroszczak United States
Sepideh Elyasi Iran
Xianglin Zhang China
I R Welshman relative to Nancy K. Hopkins United States Nancy K. Hopkins's profile →
Citations per field
00.5×1.5×
Nancy K. Hopkins · 1×
Citations per year

Countries citing papers authored by I R Welshman

Since Specialization
Citations

This map shows the geographic impact of I R Welshman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I R Welshman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I R Welshman more than expected).

Fields of papers citing papers by I R Welshman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I R Welshman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I R Welshman. The network helps show where I R Welshman may publish in the future.

Co-authorship network of co-authors of I R Welshman

This figure shows the co-authorship network connecting the top 25 collaborators of I R Welshman. A scholar is included among the top collaborators of I R Welshman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I R Welshman. I R Welshman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 90
2 102
3 69
4
Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.
203
5 24
6 14
7 7
8 25
9 28
10 15
11
Bioavailability of medroxyprogesterone acetate from three oral dosage formulations.
1
12 2
13 25
14 8
15 7
16 11
17
Utilization of long-chain free fatty acids and glucose by human leukemic blast cells.
7
18
Fatty acid utilization by L1210 murine leukemia cells.
15
19 5
20 3

About I R Welshman

I R Welshman is a scholar working on Biochemistry, Pharmacology and Analytical Chemistry, having authored 21 papers that have together received 663 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Lipid metabolism and biosynthesis (3 papers). The work is most often cited by research in Clinical Biochemistry (146 citations), Infectious Diseases (332 citations) and Pharmacology (293 citations). I R Welshman has collaborated with scholars based in United States. Frequent co-authors include Nancy K. Hopkins, Dennis J. Stalker, Edward J. Antal, Gail L. Jungbluth, J G Slatter, James P. Sams, Paul E. Fagerness, M J Hauer, R.P. Stryd and Jon Bruss. Their work appears in journals such as Diabetes Care, International Journal of Pharmaceutics and American Journal of Kidney Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026